BACKGROUND: Esophageal cancer is the malignant tumor with very poor prognosis and increasing incidence often diagnosed at very late stage, so the prognosis of affected patients is unsatisfactory, despite the development of therapeutic option such as surgery, chemotherapy and radiotherapy. Consequently, there is a great need for biomarkers to allow a tailored multimodality approach with increased efficiency. Altered expression of microRNAs has been reported in wide range of malignancies, including esophageal cancer. The aim of this study was to examine the expression levels of candidate microRNAs in esophageal cancer and evaluate their diagnostic and prognostic potential. FINDINGS: Using quantitative real-time PCR, expression levels of 9 candidate microRNAs were examined in 62 tissue samples, 23 esophageal adenocarcinomas, 22 esophageal squamous cell carcinomas and 17 adjacent esophageal mucosa samples. MicroRNA expression levels were further analyzed in regards to clinico-pathological features of esophageal cancer patients. We observed significantly decreased levels of miR-203 and increased levels of miR-21 in adenocarcinoma tissues when compared to normal mucosa. MiR-29c and miR-148 indicated good ability to distinguish between histological subtypes of esophageal cancer. MiR-203 and miR-148 were linked to disease-free survival and overall survival in esophageal adenocarcinoma patients, and miR-148 also in esophageal squamous cell carcinoma patients. CONCLUSIONS: Our data suggest that altered expression of miR-21, miR-29c, miR-148 and miR-203 are related to neoplastic transformation and progression of the disease and these microRNAs could serve as a potential diagnostic and prognostic biomarkers in esophageal cancer. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/4646922201567057.

3rd Department of Surgery University Hospital in Motol Prague Czech Republic

Department of Comprehensive Cancer Care Masaryk Memorial Cancer Institute Zluty kopec 7 Brno 656 53 Czech Republic

Department of Histology and Embryology Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc 779 00 Czech Republic

Department of Oncology General University Hospital Prague Prague Czech Republic

Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc 779 00 Czech Republic

Molecular Oncology 2 Solid Cancers Molecular Medicine Central European Institute of Technology Masaryk University Brno Czech Republic

Zobrazit více v PubMed

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. doi: 10.3322/caac.20107. PubMed DOI

Cowie A, Noble F, Underwood T. Strategies to improve outcomes in esophageal adenocarcinoma. Expert Rev Anticancer Ther. 2014;14:677-87. PubMed

Shibata A, Matsuda T, Ajiki W, Sobue T. Trend in incidence of adenocarcinoma of the esophagus in japan, 1993–2001. Jpn J Clin Oncol. 2008;38:464–468. doi: 10.1093/jjco/hyn064. PubMed DOI

Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30. doi: 10.3322/canjclin.55.1.10. PubMed DOI

Kato H, Fukuchi M, Miyazaki T, Nakajima M, Tanaka N, Inose T, et al. Surgical treatment for esophageal cancer. Current Issues Dig Surg. 2007;24:88–95. doi: 10.1159/000101894. PubMed DOI

Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microrna expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103:2257–2261. doi: 10.1073/pnas.0510565103. PubMed DOI PMC

Redova M, Poprach A, Besse A, Iliev R, Nekvindova J, Lakomy R, et al. Mir-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. Tumour Biol: J Int Soc Oncodev Biol Med. 2013;34:481–491. doi: 10.1007/s13277-012-0573-2. PubMed DOI

Saad R, Chen Z, Zhu S, Jia P, Zhao Z, Washington MK, et al. Deciphering the unique microrna signature in human esophageal adenocarcinoma. PLoS One. 2013;8:e64463. doi: 10.1371/journal.pone.0064463. PubMed DOI PMC

Wu X, Ajani JA, Gu J, Chang DW, Tan W, Hildebrandt MA, et al. Microrna expression signatures during malignant progression from barrett’s esophagus to esophageal adenocarcinoma. Cancer Prev Res (Phila) 2013;6:196–205. doi: 10.1158/1940-6207.CAPR-12-0276. PubMed DOI PMC

Wang HB, Jiang ZB, Li M. Research on the typical mirna and target genes in squamous cell carcinoma and adenocarcinoma of esophagus cancer with DNA microarray. Pathol Oncol Res: 2014; Feb 12. PubMed

Fassan M, Volinia S, Palatini J, Pizzi M, Fernandez-Cymering C, Balistreri M, et al. Microrna expression profiling in the histological subtypes of barrett’s metaplasia. Clin Translat Gastroenterol. 2013;4:e34. doi: 10.1038/ctg.2013.5. PubMed DOI PMC

Fu C, Dong W, Wang Z, Li H, Qin Q, Li B. The expression of mir-21 and mir-375 predict prognosis of esophageal cancer. Biochem Biophys Res Commun. 2014;446:1197–1203. doi: 10.1016/j.bbrc.2014.03.087. PubMed DOI

Kim J, Zhang Y, Skalski M, Hayes J, Kefas B, Schiff D, et al. Microrna-148a is a prognostic oncomir that targets mig6 and bim to regulate egfr and apoptosis in glioblastoma. Cancer Res. 2014;74:1541–1553. doi: 10.1158/0008-5472.CAN-13-1449. PubMed DOI PMC

Sakamoto N, Naito Y, Oue N, Sentani K, Uraoka N, Zarni Oo H, et al. Microrna-148a is downregulated in gastric cancer, targets mmp7, and indicates tumor invasiveness and poor prognosis. Cancer Sci. 2014;105:236–243. doi: 10.1111/cas.12330. PubMed DOI PMC

Tchernitsa O, Kasajima A, Schafer R, Kuban RJ, Ungethum U, Gyorffy B, et al. Systematic evaluation of the mirna-ome and its downstream effects on mrna expression identifies gastric cancer progression. J Pathol. 2010;222:310–319. doi: 10.1002/path.2759. PubMed DOI

Wang SH, Li X, Zhou LS, Cao ZW, Shi C, Zhou CZ, et al. Microrna-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition. Tumour Biol: J Int Soc Oncodev Biol Med. 2013;34:3705–3712. doi: 10.1007/s13277-013-0954-1. PubMed DOI

Zhang JP, Zeng C, Xu L, Gong J, Fang JH, Zhuang SM. Microrna-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting met/snail signaling. Oncogene. 2014;33:4069–4076. doi: 10.1038/onc.2013.369. PubMed DOI

Zheng B, Liang L, Wang C, Huang S, Cao X, Zha R, et al. Microrna-148a suppresses tumor cell invasion and metastasis by downregulating rock1 in gastric cancer. Clin Cancer Res: Off J American Assoc Cancer Res. 2011;17:7574–7583. doi: 10.1158/1078-0432.CCR-11-1714. PubMed DOI

Kern E, Lin D, Larson A, Yang GY, Taft T, Zalewski A, et al. Prospective assessment of the diagnostic utility of esophageal brushings in adults with eosinophilic esophagitis. Dis Esophagus. 2014; Dec 17. PubMed